Copaxone

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from Glatopa)
Jump to: navigation, search

Copaxone or glatopa, and glatiramer, its generic form, is a drug licensed to reduce relapses in patients with multiple sclerosis.[1]

ME/CFS[edit | edit source]

Dr. Ron Davis on Copaxone in ME/CFS. Inaugural Harvard Symposium, Sep 2019.

Ron Davis of the Open Medicine Foundation reports that when the nanoneedle electrical impedance test on ME/CFS cells was used, Copaxone made the cells respond in the same way as healthy cells did, suggesting it is a potential treatment for ME/CFS.[2]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

nanoneedle A device with microscopic dimensions which measures electrical impedance across a blood cell. According to Ron Davis, the nanoneedle measured increased electrical impedance in the blood cells of 10 ME/CFS patients when stressed with salt, but not in healthy controls. Accordingly, this device has been proposed as a potential diagnostic test to distinguish ME/CFS patients from healthy controls. (Learn more: www.omf.ngo)

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.